BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Podkowinski D, Orlowski-Wimmer E, Zlabinger G, Pollreisz A, Mursch-Edlmayr AS, Mariacher S, Ring M, Bolz M. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema. Acta Ophthalmol 2020;98:e407-15. [PMID: 31736269 DOI: 10.1111/aos.14297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Iovino C, Mastropasqua R, Lupidi M, Bacherini D, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Carnevali A, D'Aloisio R, Cerquaglia A, Finocchio L, Govetto A, Erba S, Triolo G, Di Zazzo A, Forlini M, Vagge A, Giannaccare G. Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics 2020;12:E703. [PMID: 32722556 DOI: 10.3390/pharmaceutics12080703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Midena E, Frizziero L, Midena G, Pilotto E. Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2021;259:3549-60. [PMID: 34216255 DOI: 10.1007/s00417-021-05285-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
3 Rittiphairoj T, Mir TA, Li T, Virgili G. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 2020;11:CD005656. [PMID: 33206392 DOI: 10.1002/14651858.CD005656.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mao J, Zhang S, Zheng Z, Deng X, Liu C, Chen Y, Zhao S, Zhang Y, Shen L. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography. Acta Ophthalmol 2022;100:e891-8. [PMID: 34403203 DOI: 10.1111/aos.15008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Filippov VM, Petrachkov DV, Budzinskaya MV, Matyushchenko AG. [The role of neurodegeneration biomarkers in the management of patients with diabetic retinopathy]. Vestn Oftalmol 2021;137:314-22. [PMID: 34669343 DOI: 10.17116/oftalma2021137052314] [Reference Citation Analysis]
6 Lei J, Ding G, Xie A, Hu Y, Gao N, Fan X. Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy. PLoS One 2021;16:e0248235. [PMID: 33667285 DOI: 10.1371/journal.pone.0248235] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Minaker SA, Mason RH, Lahaie Luna G, Farahvash A, Garg A, Bhambra N, Bapat P, Muni RH. Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta-analysis. Acta Ophthalmol 2022;100:e53-70. [PMID: 33945678 DOI: 10.1111/aos.14891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]